Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
October 16, 2018
Patent Application Number
15808419
Date Filed
November 9, 2017
Patent Citations Received
Patent Primary Examiner
Patent abstract
The invention relates to anti-epidermal growth factor (EGFR) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
